The following shared lab equipment is available for research or teaching purposes, however users of shared equipment must attend a semester orientation/training session and receive authorization for ...

The company supplies laboratory equipment and instruments for drug manufacturers and biotech companies. Bio-Rad also produces ...

Medical laboratory scientists collect samples and perform lab tests, calibrate and maintain equipment, and perform statistical ... immunology, molecular biology, clinical chemistry, medical ...

HERCULES, Calif. (AP) — HERCULES, Calif. (AP) — Bio-Rad Laboratories Inc. (BIO.B) on Wednesday reported third-quarter profit of $653.2 million. The Hercules, California-based company said it had ...

Have you evaluated the performance of Bio-Rad Laboratories' (BIO) international operations during the quarter that concluded in September 2024? Considering the extensive worldwide presence of this ...

This course covers the basic experimental approaches used in studying evolution, ecology, and community biology. Students will be taught how to use scientific instruments and laboratory techniques ...

RBC Capital analyst Conor McNamara maintained a Buy rating on Bio-Rad Laboratories (BIO – Research Report) on October 23 and set a price ...

Bio-Rad Laboratories (BIO) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus ...

Search our database to locate instruments ... bio bay. Login online to reserve instrument time, training, and services from any location and communicate directly with our professional technical staff.

AV Equipment: Equipment must be returned to the Biology Office immediately after use (please note the office closes at 4:30 pm). If this is not possible, it must be locked in a faculty member's office ...

In a report released today, Conor McNamara from RBC Capital reiterated a Buy rating on Bio-Rad Laboratories (BIO – Research Report), with ...

Bio-Rad Laboratories (BIO) came out with quarterly earnings of $2.01 per share, beating the Zacks Consensus Estimate of $1.28 per share. This compares to earnings of $2.33 per share a year ago. These ...